Paid Clinical Trials in Texas

Texas has 5,331 paid clinical trials enrolling now across cities including Houston, Dallas and San Antonio. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Research sites in Texas include MD Anderson Cancer Center, Baylor College of Medicine and UT Southwestern, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 31, 2026.

Filter results

Filter results

State

City

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

4,648 clinical trials

A Study on TLC590 for Managing Postsurgical Pain

for Postsurgical Pain Management

Drug: TLC590

Sites in Houston & Bellaire

Sponsor: TLC Biopharmaceuticals, Inc.

Sex: All·Age: 18 - 70

Code: NCT06574269·Phase 2·Recruiting·Listed Aug 2024

Apply to this trial

A Study of LM-24C5 For Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Dallas +5 more locations

Sponsor: LaNova Medicines Limited

Sex: All·Age: 18+

Code: NCT06187402·Phase 1, Phase 2·Recruiting·Listed Jan 2024

Apply to this trial

Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC)

for Adenoid Cystic Carcinoma

Sites in Houston +7 more locations

Sponsor: Rgenta Therapeutics Inc

Sex: All·Age: 18+

Code: NCT06462183·Phase 1·Recruiting·Listed Jun 2024

Apply to this trial

Pharmacokinetics (PK) and Safety of Zanzalintinib in Participants With Moderate Hepatic Impairment (HI)

for Hepatic Impairment

Sites in San Antonio +1 more location

Sponsor: Exelixis

Sex: All·Age: 18 - 75·Accepts healthy volunteers

Code: NCT06962332·Phase 1·Recruiting·Listed May 2025

Apply to this trial

A Study Evaluating APG-115 as a Single Agent or in Combination With APG-2575 in Subjects With R/R T-PLL and NHL

for T-Prolymphocytic Leukemia

1 location in Houston

Sponsor: Ascentage Pharma Group Inc.

Sex: All·Age: 18+

Code: NCT04496349·Phase 2·Recruiting·Listed Aug 2020

Apply to this trial

A Study of KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency

for Alpha 1-Antitrypsin Deficiency

Sites in The Woodlands +2 more locations

Sponsor: Krystal Biotech, Inc.

Sex: All·Age: 18 - 70

Code: NCT06049082·Phase 1·Recruiting·Listed Sep 2023

Apply to this trial

Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-Transplant

for E Coli Infections

Sites in Houston +7 more locations

Sponsor: SNIPR Biome Aps.

Sex: All·Age: 18+

Code: NCT06938867·Phase 1, Phase 2·Recruiting·Listed Apr 2025

Apply to this trial

Evaluation of Cataract Surgery Outcomes in Patients With Prior Laser Vision Correction Implanted With the CT LUCIA Lens

for Postoperative Visual Outcomes Following Cataract Surgery in Patients With Prior Myopic Corneal Laser Vision Correction

Sites in Sugar Land +1 more location

Sponsor: Carl Zeiss Meditec AG

Sex: All·Age: 18+

Code: NCT07084545·Recruiting·Listed Jul 2025

Apply to this trial

Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System

for Cancer

Sites in Dallas +4 more locations

Sponsor: RefleXion Medical

Sex: All·Age: All ages

Code: NCT05406167·Recruiting·Listed Jun 2022

Apply to this trial

A Modular Phase 1/2 Study With CT7439 in Participants With Solid Malignancies

for Solid Malignancies

Sites in Dallas, San Antonio +1 more location

Sponsor: Carrick Therapeutics Limited

Sex: All·Age: 18+

Code: NCT06600789·Phase 1, Phase 2·Recruiting·Listed Sep 2024

Apply to this trial

A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma

for Advanced Hepatocellular Carcinoma

Sites in Houston, Dallas +5 more locations

Sponsor: Iterion Therapeutics

Sex: All·Age: 18+

Code: NCT05797805·Phase 1, Phase 2·Recruiting·Listed Apr 2023

Apply to this trial

A Study on How NNC0174-1213 Works in People With Overweight or Obesity.

for Obesity

Sites in San Antonio +1 more location

Sponsor: Novo Nordisk A/S

Sex: Male·Age: 18 - 55

Code: NCT06719011·Phase 1·Recruiting·Listed Dec 2024

Apply to this trial

A Study of Oral E1018 in Healthy Adult Participants

for Malaria

1 location in Austin

Sponsor: Eisai Inc.

Sex: All·Age: 18 - 55·Accepts healthy volunteers

Code: NCT06854042·Phase 1·Recruiting·Listed Mar 2025

Apply to this trial

Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advanced or Metastatic NSCLC or Solid Tumors With Bone Metastases

for Carcinoma, Non-Small-Cell Lung Cancer

Sites in Tyler +4 more locations

Sponsor: Kiromic BioPharma Inc.

Sex: All·Age: 18+

Code: NCT06069570·Phase 1·Recruiting·Listed Oct 2023

Apply to this trial

Comprehensive Assessment of Cancer Theranostic Response

for Prostate Cancer

Sites in Houston +1 more location

Sponsor: AIQ Solutions

Sex: Male·Age: 18+

Code: NCT06815354·Recruiting·Listed Feb 2025

Apply to this trial

Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)

for CIN 2/3

Sites in Houston +6 more locations

Sponsor: Frantz Viral Therapeutics, LLC

Sex: Female·Age: 25 - 100

Code: NCT04098744·Phase 2·Recruiting·Listed Sep 2019

Apply to this trial

Pounce™ Thrombectomy System Retrospective Registry

for Peripheral Arterial Disease

Sites in Austin +6 more locations

Sponsor: SurModics, Inc.

Sex: All·Age: 18+

Code: NCT05868161·Recruiting·Listed May 2023

Apply to this trial

A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer

for Advanced Solid Tumor

Sites in Houston +3 more locations

Sponsor: Edgewood Oncology Inc.

Sex: All·Age: 18+

Code: NCT04872166·Phase 1·Recruiting·Listed May 2021

Apply to this trial

Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma

for Glioblastoma, IDH-wildtype

Sites in Houston +6 more locations

Sponsor: Orbus Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT05879367·Phase 1·Recruiting·Listed May 2023

Apply to this trial

North American Comfilcon A Clinical Study

for Astigmatism

Sites in Corpus Christi +3 more locations

Sponsor: CooperVision International Limited (CVIL)

Sex: All·Age: 8 - 75

Code: NCT06902584·Recruiting·Listed Mar 2025

Apply to this trial

Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors

for Advanced Cancer

Sites in Dallas +6 more locations

Sponsor: Qurient Co., Ltd.

Sex: All·Age: 18+

Code: NCT05394103·Phase 1, Phase 2·Recruiting·Listed May 2022

Apply to this trial

A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849

for Advanced Solid Tumor

Sites in Dallas, San Antonio +3 more locations

Sponsor: 1ST Biotherapeutics, Inc.

Sex: All·Age: 18+

Code: NCT05761223·Phase 1, Phase 2·Recruiting·Listed Mar 2023

Apply to this trial

MAD Study to Assess the Safety, Tolerability, PKs and Efficacy of YJ001 for Spray Use in Patients With DPNP

for Diabetic Peripheral Neuropathic Pain

1 location in Fredericksburg

Sponsor: Zhejiang Hanmai Pharmaceutical Technology Co., Ltd.

Sex: All·Age: 18 - 80

Code: NCT06361108·Phase 1·Recruiting·Listed Apr 2024

Apply to this trial

BostonGene and Exigent Genomic INsight Study

for Breast Cancer

Sites in Houston +6 more locations

Sponsor: BostonGene

Sex: All·Age: 18+

Code: NCT06272864·Recruiting·Listed Feb 2024

Apply to this trial

Reducing Pregnancy Risks: The Mastery Lifestyle Intervention

for Mental Health Wellness 1

1 location in Webster

Sponsor: Microgen LLC

Sex: Female·Age: 18 - 45

Code: NCT05012072·Recruiting·Listed Aug 2021

Apply to this trial

A Multi-Site Clinical Evaluation of the LIAISON NES FLU A/B, RSV & COVID-19 Assay in Symptomatic Patients

for Influenza a

Sites in McAllen +2 more locations

Sponsor: DiaSorin Molecular LLC

Sex: All·Age: All ages

Code: NCT06672692·Recruiting·Listed Nov 2024

Apply to this trial

This is a Study to Evaluate the Safety and Tolerability of ABL503, and to Determine the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) of ABL503 in Subjects with Any Progressive Locally Advanced or Metastatic Solid Tumors

for Advanced Solid Tumor

Sites in San Antonio +4 more locations

Sponsor: ABL Bio, Inc.

Sex: All·Age: 18+

Code: NCT04762641·Phase 1·Recruiting·Listed Feb 2021

Apply to this trial

Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care.

for Diabetic Foot Ulcer

2 locations in Corpus Christi

Sponsor: Estar Medical dba Medical Technologies, LTD

Sex: All·Age: 18 - 80

Code: NCT06810726·Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

Maestro 1.1 Post-Market Registry

for Surgery

Sites in Cedar Park +5 more locations

Sponsor: Moon Surgical

Sex: All·Age: 18 - 100

Code: NCT06103136·Recruiting·Listed Oct 2023

Apply to this trial

APrevent-VOIS-Implant-002 - a Two-Part, Open-Label, Non-Randomized Multicenter Study

for Paralysis, Unilateral, Vocal Cord

Sites in Houston +3 more locations

Sponsor: APrevent Biotech GmbH

Sex: All·Age: 18 - 80·Accepts healthy volunteers

Code: NCT05119842·Recruiting·Listed Nov 2021

Apply to this trial

Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors

for Neuroendocrine Tumors

Sites in Dallas +3 more locations

Sponsor: Aadi Bioscience, Inc.

Sex: All·Age: 18+

Code: NCT05997056·Phase 2·Recruiting·Listed Aug 2023

Apply to this trial

Examining the Effects of Theta Burst TMS on Brain Connectivity and Balance Ability in Older Adults With Balance Problems

for Aging

1 location in Houston

Sponsor: Weinberg Medical Physics LLC

Sex: All·Age: 65+

Code: NCT06779188·EARLY_Phase 1·Recruiting·Listed Jan 2025

Apply to this trial

Study of Olverembatinib (HQP1351) in Patients With CP-CML

for Chronic Myeloid Leukemia

1 location in Houston

Sponsor: Ascentage Pharma Group Inc.

Sex: All·Age: 18 - 99

Code: NCT06423911·Phase 3·Recruiting·Listed May 2024

Apply to this trial

SportsPro: Post-Market Clinical Follow Up Study

for Shoulder Injuries

Sites in San Antonio +2 more locations

Sponsor: Stryker Endoscopy

Sex: All·Age: 18+

Code: NCT06320925·Recruiting·Listed Mar 2024

Apply to this trial

Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma

for Pancreatic Adenocarcinoma

3 locations in Houston

Sponsor: Diakonos Oncology Corporation

Sex: All·Age: 18+

Code: NCT04157127·Phase 1·Recruiting·Listed Nov 2019

Apply to this trial

Phase I/II Study of SKG0106 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)

for Neovascular Age-related Macular Degeneration

Sites in Katy +3 more locations

Sponsor: Skyline Therapeutics (US) Inc.

Sex: All·Age: 50+

Code: NCT05986864·Phase 1, Phase 2·Recruiting·Listed Aug 2023

Apply to this trial

A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

for Cancer

Sites in San Antonio, Austin +2 more locations

Sponsor: OncoResponse, Inc.

Sex: All·Age: 18+

Code: NCT06090266·Phase 1, Phase 2·Recruiting·Listed Oct 2023

Apply to this trial

A Study Evaluating the Safety and Efficacy of HB0036 in Subjects With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in San Antonio +2 more locations

Sponsor: Shanghai Huaota Biopharmaceutical Co., Ltd.

Sex: All·Age: 18+

Code: NCT05417321·Phase 1, Phase 2·Recruiting·Listed Jun 2022

Apply to this trial

A Study of IBI363 in Subjects with Advanced Solid Malignancies

for Melanoma

Sites in Houston +8 more locations

Sponsor: Innovent Biologics (Suzhou) Co. Ltd.

Sex: All·Age: 18+

Code: NCT06281678·Phase 2·Recruiting·Listed Feb 2024

Apply to this trial

Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's Lymphoma

for Refractory Non-Hodgkin Lymphoma

Sites in Houston +2 more locations

Sponsor: SIRPant Immunotherapeutics, Inc.

Sex: All·Age: 18+

Code: NCT05967416·Phase 1·Recruiting·Listed Aug 2023

Apply to this trial